Translate to...

Older, critically ill patients with COVID-19 may have increased risk of bradycardia with lopinavir and ritonavir

Older, critically ill patients with COVID-19 may have increased risk of bradycardia with lopinavir and ritonavir

Older, critically ill patients with COVID-19 who received a combination of the antiretroviral medications lopinavir and ritonavir experienced bradycardia, a slow heart rate, more often, according to new research published today in Circulation: Arrhythmia and Electrophysiology, an American Heart Association journal.